Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C] PIB

被引:21
作者
Ito, Hiroshi [1 ,3 ]
Shinotoh, Hitoshi [1 ]
Shimada, Hitoshi [1 ]
Miyoshi, Michie [1 ]
Yanai, Kazuhiko [2 ]
Okamura, Nobuyuki [2 ]
Takano, Harumasa [1 ]
Takahashi, Hidehiko [1 ]
Arakawa, Ryosuke [1 ]
Kodaka, Fumitoshi [1 ]
Ono, Maiko [1 ]
Eguchi, Yoko [1 ]
Higuchi, Makoto [1 ]
Fukumura, Toshimitsu [1 ]
Suhara, Tetsuya [1 ]
机构
[1] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan
[2] Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi 980, Japan
[3] Natl Inst Radiol Sci, Mol Imaging Ctr, Biophys Program, Inage Ku, Chiba 2638555, Japan
关键词
Amyloid; Alzheimer; PET; FACT; PIB; VOXEL-BASED MORPHOMETRY; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; IN-VIVO; PET; BETA; PLAQUES; DEMENTIA; BINDING; RADIOLIGAND;
D O I
10.1007/s00259-013-2620-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The characteristic neuropathological changes in Alzheimer's disease (AD) are deposition of amyloid senile plaques and neurofibrillary tangles. The F-18-labeled amyloid tracer, [F-18]2-[(2-{(E)-2-[2-(dimethylamino)-1,3-thiazol-5-yl]vinyl}-1,3-benzoxazol-6-yl)oxy]-3-fluoropropan-1-ol (FACT), one of the benzoxazole derivatives, was recently developed. In the present study, deposition of amyloid senile plaques was measured by positron emission tomography (PET) with both [C-11]Pittsburgh compound B (PIB) and [F-18]FACT in the same subjects, and the regional uptakes of both radiotracers were directly compared. Methods Two PET scans, one of each with [C-11]PIB and [F-18]FACT, were performed sequentially on six normal control subjects, two mild cognitive impairment (MCI) patients, and six AD patients. The standardized uptake value ratio of brain regions to the cerebellum was calculated with partial volume correction using magnetic resonance (MR) images to remove the effects of white matter accumulation. Results No significant differences in the cerebral cortical uptake were observed between normal control subjects and AD patients in [F-18]FACT studies without partial volume correction, while significant differences were observed in [C-11]PIB. After partial volume correction, the cerebral cortical uptake was significantly larger in AD patients than in normal control subjects for [F-18]FACT studies as well as [C-11]PIB. Relatively lower uptakes of [C-11]PIB in distribution were observed in the medial side of the temporal cortex and in the occipital cortex as compared with [F-18]FACT. Relatively higher uptake of [C-11]PIB in distribution was observed in the frontal and parietal cortices. Conclusion Since [F-18]FACT might bind more preferentially to dense-cored amyloid deposition, regional differences in cerebral cortical uptake between [C-11]PIB and [F-18]FACT might be due to differences in regional distribution between diffuse and dense-cored amyloid plaque shown in the autoradiographic and histochemical assays of postmortem AD brain sections.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 50 条
  • [21] Subacute Ischemic Stroke Is Associated With Focal 11C PiB Positron Emission Tomography Retention But Not With Global Neocortical Aβ Deposition
    Ly, John V.
    Rowe, Christopher C.
    Villemagne, Victor L.
    Zavala, Jorge A.
    Ma, Henry
    Sahathevan, Ramesh
    O'Keefe, Graeme
    Gong, Sylvia J.
    Gunawan, Rico
    Churilov, Leonid
    Saunder, Tim
    Ackerman, Uwe
    Tochon-Danguy, Henri
    Donnan, Geoffrey A.
    STROKE, 2012, 43 (05) : 1341 - 1346
  • [22] Synthesis of 18F-labelled 2-(4′-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB
    Serdons, K.
    Verduyckt, T.
    Vanderghinste, D.
    Cleynhens, J.
    Borghgraef, P.
    Vermaelen, P.
    Terwinghe, C.
    Van Leuven, F.
    Van Laere, K.
    Kung, H.
    Bormans, G.
    Verbruggen, A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 602 - 605
  • [23] [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
    Bruck, A.
    Virta, J. R.
    Koivunen, J.
    Koikkalainen, J.
    Scheinin, N. M.
    Helenius, H.
    Nagren, K.
    Helin, S.
    Parkkola, R.
    Viitanen, M.
    Rinne, J. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (10) : 1567 - 1572
  • [24] Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis
    Heurling, Kerstin
    Leuzy, Antoine
    Zimmer, Eduardo R.
    Lubberink, Mark
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 362 - 373
  • [25] Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652
    Brust, P
    Zessin, J
    Kuwabara, H
    Pawelke, B
    Kretzschmar, M
    Hinz, R
    Bergman, J
    Eskola, O
    Solin, O
    Steinbach, J
    Johannsen, B
    SYNAPSE, 2003, 47 (02) : 143 - 151
  • [26] Diagnostic Accuracy of [11C]PIB Positron Emission Tomography for Detection of Cardiac Amyloidosis
    Rosengren, Sara
    Clemmensen, Tor Skibsted
    Tolbod, Lars
    Granstam, Sven-Olof
    Eiskjaer, Hans
    Wikstrom, Gerhard
    Vedin, Ola
    Kero, Tanja
    Lubberink, Mark
    Harms, Hendrik J.
    Flachskampf, Frank A.
    Baron, Tomasz
    Carlson, Kristina
    Mikkelsen, Fabian
    Antoni, Gunnar
    Andersen, Niels Frost
    Poulsen, Steen Hvitfeldt
    Sorensen, Jens
    JACC-CARDIOVASCULAR IMAGING, 2020, 13 (06) : 1337 - 1347
  • [27] Florbetapir (18F) for brain amyloid positron emission tomography: Highlights on the European marketing approval
    Cortes-Blanco, Anabel
    Prieto-Yerro, Concha
    Martinez-Lazaro, Raul
    Zamora, Javier
    Jimenez-Huete, Adolfo
    Haberkamp, Marion
    Pohly, Johannes
    Enzmann, Harald
    Zinserling, Joerg
    Strassmann, Valerie
    Broich, Karl
    ALZHEIMERS & DEMENTIA, 2014, 10 (05) : S395 - S399
  • [28] [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease
    Shizuo Hatashita
    Hidetomo Yamasaki
    Yutaka Suzuki
    Kumiko Tanaka
    Daichi Wakebe
    Hideki Hayakawa
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 290 - 300
  • [29] Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging
    Hatashita, Shizuo
    Yamasaki, Hidetomo
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 995 - 1003
  • [30] Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects
    Mountz, James M.
    Laymon, Charles M.
    Cohen, Ann D.
    Zhang, Zheng
    Price, Julie C.
    Boudhar, Sanaa
    McDade, Eric
    Aizenstein, Howard J.
    Klunk, William E.
    Mathis, Chester A.
    NEUROIMAGE-CLINICAL, 2015, 9 : 592 - 598